Handelsavisen
prelaunch
Companies Basic Materials BRIB.BO
BR
BRIB.BO BSE (India) Commodity Chemicals

Brib.Bo

$243,85
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,96 %
Op margin
5,4 %
ROE
11,1 %
Net margin
2,5 %
Debt / equity
0,71
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

BRIB.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.

Business. BRIB.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryCommodity Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
11,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning BRIB.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to BRIB.BO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    BRIB.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustryCommodity Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    BRIB.BO has a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing, and a current ratio of 1.13, suggesting limited short-term liquidity cushion. The company's free cash flow of INR 74.58 million reflects its ability to generate cash after capital expenditures, though the negative net cash position after subtracting total debt raises concerns about liquidity risk.

    The company's return on equity (ROE) of 11.12% and return on assets (ROA) of 3.68% are below the typical thresholds for capital-intensive chemical firms, which often aim for ROE above 15% and ROA above 5%. This suggests that BRIB.BO is underperforming in terms of capital efficiency and asset utilization relative to industry norms.

    BRIB.BO's revenue is concentrated in a single business segment, as disclosed in its latest financials, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic downturns and regulatory shifts, particularly in the chemical manufacturing sector.

    The company's revenue growth is not explicitly provided in the latest financials, but the operating income of INR 180.60 million and net income of INR 84.93 million suggest a stable but modest performance. The capital expenditure of INR -110.35 million indicates a reduction in investment, which may signal a strategic shift or financial constraint.

    BRIB.BO faces medium liquidity risk due to its current ratio of 1.13 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution events reported in the latest filings. However, the company's reliance on debt financing and limited free cash flow could increase dilution pressure in the future.

    No recent events or filings are disclosed in the available data, which limits the ability to assess the company's response to market conditions or strategic initiatives.

    Key takeaways
    • BRIB.BO has a moderate debt-to-equity ratio but faces liquidity concerns due to a low current ratio and negative net cash position.
    • The company's ROE and ROA are below industry benchmarks, indicating suboptimal capital and asset efficiency.
    • Revenue is concentrated in a single segment with no geographic diversification, increasing exposure to regional risks.
    • Capital expenditures have declined, suggesting a potential strategic shift or financial constraint.
    • The company faces medium liquidity risk and low dilution risk, but its financial structure could become more vulnerable in a downturn.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $243,85
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $763.5M
    Net cash
    -$544.1M
    Current ratio
    1.1
    Debt / equity
    0.7
    ROA
    3.7%
    ROE
    11.1%
    Cash conversion
    132.0%
    CapEx / revenue
    -3.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin5,4 %Below median
    Net Margin2,5 %Below median
    ROE11,1 %Above P75
    Capex / Rev-3,3 %Above median
    D/E0,71Below median
    Cash Conv1,32Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • BRIB.BO Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    3.2Kshares short-72.0% vs prior
    1days to cover
    0.8%short of daily vol
    3fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BRIB.BOCanonical
    BSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage